Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
British Journal of Cancer
|
March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
F H Blackhall, M Ranson, J A Radford, et al.
Gynecologic Oncology
|
September 24, 2004
A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer
A Clamp, M Adams, R Atkinson, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
February 7, 2020
Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition
A M Sowerbutts, S Lal, J Sremanakova, et al.
British Journal of Cancer
|
January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer
A R Clamp, J Mäenpää, D Cruickshank, et al.
British Journal of Cancer
|
March 25, 2000
Requirement for expert histopathological assessment of ovarian cancer and borderline tumors
P S Sengupta, J H Shanks, C H Buckley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2007
The neoadjuvant approach in the treatment of patients with advanced epithelial ovarian carcinoma
D D Rosa, N C Ton, A Clamp, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Journal of Cancer Research and Clinical Oncology
|
October 27, 2005
Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor
M K Whitworth, A Sheen, D D Rosa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
p53 and related proteins in epithelial ovarian cancer
P S Sengupta, A T McGown, V Bajaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
M Zweifel, G C Jayson, N S Reed, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
British Journal of Cancer
|
March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma
F H Blackhall, M Ranson, J A Radford, et al.
Gynecologic Oncology
|
September 24, 2004
A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer
A Clamp, M Adams, R Atkinson, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
February 7, 2020
Dealing with loss: food and eating in women with ovarian cancer on parenteral nutrition
A M Sowerbutts, S Lal, J Sremanakova, et al.
British Journal of Cancer
|
January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer
A R Clamp, J Mäenpää, D Cruickshank, et al.
British Journal of Cancer
|
March 25, 2000
Requirement for expert histopathological assessment of ovarian cancer and borderline tumors
P S Sengupta, J H Shanks, C H Buckley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 16, 2007
The neoadjuvant approach in the treatment of patients with advanced epithelial ovarian carcinoma
D D Rosa, N C Ton, A Clamp, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
Journal of Cancer Research and Clinical Oncology
|
October 27, 2005
Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor
M K Whitworth, A Sheen, D D Rosa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
p53 and related proteins in epithelial ovarian cancer
P S Sengupta, A T McGown, V Bajaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
M Zweifel, G C Jayson, N S Reed, et al.
Page
of 7